These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1876530)

  • 1. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma.
    Giannini A; Bianchi S; Messerini L; Gallo O; Gallina E; Asprella Libonati G; Olmi P; Zampi G
    Pathol Res Pract; 1991 May; 187(4):496-502. PubMed ID: 1876530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance.
    Gallo O; Bianchi S; Giannini A; Gallina E; Libonati GA; Fini-Storchi O
    Laryngoscope; 1991 May; 101(5):487-93. PubMed ID: 2030628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans cells in nasopharyngeal carcinoma in relation to prognosis.
    Ma CX; Jia TC; Li XR; Zhand ZF; Yiao CB
    In Vivo; 1995; 9(3):225-9. PubMed ID: 8562888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.
    Vera-Sempere FJ; Burgos JS; Botella MS; Morera C
    Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients.
    Rubio L; Burgos JS; Lopez-Guerrero JA; Morera C; Vera-Sempere FJ
    Pathol Res Pract; 2002; 198(2):97-102. PubMed ID: 11928871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell antigen marker expression in nasopharyngeal carcinoma.
    Zhong XY; Senba M; Gu JN; Itakura H
    Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
    Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
    Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
    Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
    Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma.
    Ho SY; Guo HR; Chen HH; Hsiao JR; Jin YT; Tsai ST
    Head Neck; 2004 Nov; 26(11):977-83. PubMed ID: 15390195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local infiltration of T-lymphocyte subsets as a prognostic indicator in patients with nasopharyngeal carcinoma.
    Hsu MM
    Ear Nose Throat J; 1990 Aug; 69(8):543-7. PubMed ID: 2204526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship among lymphatic metastasis, pericancerous lymphocytic reaction and dendritic cell infiltration in laryngeal carcinoma cells].
    Feng Y; Zhang B; Tan H; Su H; He W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):264-6. PubMed ID: 12761992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinomas and malignant lymphomas: an immunohistochemical analysis of 74 cases.
    Sugimoto T; Hashimoto H; Enjoji M
    Laryngoscope; 1990 Jul; 100(7):742-8. PubMed ID: 2141889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent.
    Oudejans JJ; Harijadi H; Kummer JA; Tan IB; Bloemena E; Middeldorp JM; Bladergroen B; Dukers DF; Vos W; Meijer CJ
    J Pathol; 2002 Dec; 198(4):468-75. PubMed ID: 12434416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies.
    Jondal M; Klein G
    Biomedicine; 1975 Jun; 23(5):163-5. PubMed ID: 1081410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.